Social deprivation is associated with poor kidney transplantation outcome in children.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
09 2019
Historique:
received: 07 09 2018
revised: 30 04 2019
accepted: 02 05 2019
pubmed: 4 8 2019
medline: 21 10 2020
entrez: 4 8 2019
Statut: ppublish

Résumé

Socioeconomic status is an important determinant of health. Its impact on kidney transplantation outcome has been studied among adults but data in children are scarce, especially in Europe. Here, we investigate the association between the level of social deprivation (determined by the continuous score European Deprivation Index) and graft failure risk in pediatric kidney transplant recipients. All patients listed under 18 years of age who received a first kidney transplant between 2002 and 2014 in France were included. Of 1050 kidney transplant recipients (males 59%, median age at transplantation 13.2 years, preemptive transplantation 23%), 211 graft failures occurred within a median followup of 5.9 years. Thirty-seven percent of these patients belong to the most deprived quintile, suggesting that deprivation is more frequent in pediatric patients with end-stage kidney disease (ESKD) than in the general population. Five- and ten-year graft survival were 85% and 69%, respectively, in the most deprived quintile vs. 90% and 83%, respectively, in the least deprived quintile. At any time after transplantation, patients in the most deprived quintile had almost a two-fold higher hazard of graft failure compared with the least deprived quintile, after adjustment for age at renal replacement therapy, duration of dialysis, primary kidney disease, and rural/urban living environment (hazard ratio 1.99; 95% confidence interval 1.20-3.28). The hazard of graft failure did not differ significantly between girls and boys. Thus, our findings suggest a lower socioeconomic status is independently associated with poor graft outcome in pediatric kidney transplantation.

Identifiants

pubmed: 31375259
pii: S0085-2538(19)30530-7
doi: 10.1016/j.kint.2019.05.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-776

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Bénédicte Driollet (B)

University of Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France. Electronic address: benedicte.driollet@u-bordeaux.fr.

Florian Bayer (F)

Agence de la Biomédecine, La Plaine-Saint Denis, France.

Valérie Chatelet (V)

Department of Nephrology, Caen University Hospital, Caen, France.

Marie-Alice Macher (MA)

Agence de la Biomédecine, La Plaine-Saint Denis, France; Pediatric Nephrology Unit, Robert Debré Hospital, Centre de Référence Maladies rénales rares Marhea, APHP, Paris, France.

Rémi Salomon (R)

Pediatric Nephrology Unit, Necker Enfants-Malades Hospital, Centre de Référence Maladies rénales rares Marhea, APHP, Paris Descartes University, Paris, France.

Bruno Ranchin (B)

Pediatric Nephrology Unit, Femme-Mère-Enfant Hospital, Lyon University Hospital, Centre de Référence Maladies rénales rares Nephrogones, Bron, France.

Gwenaelle Roussey (G)

Pediatric Nephrology Unit, Femme-Enfant-Adolescent Hospital, Nantes University Hospital, Nantes, France.

Annie Lahoche (A)

Pediatric Nephrology Unit, Jeanne de Flandre Hospital, Lille University Hospital, Lille, France.

Florentine Garaix (F)

Pediatric Nephrology Unit, Timone-Enfants Hospital, Marseille University Hospital, Marseille, France.

Stéphane Decramer (S)

Pediatric Nephrology Unit, Children's Hospital, Toulouse University Hospital, Centre de Référence Maladies rénales rares Sorare, Toulouse, France.

Elodie Mérieau (E)

Pediatric Nephrology Unit, Clocheville Hospital, Tours University Hospital, Tours, France.

Marc Fila (M)

Pediatric Nephrology Unit, Arnaud de Villeneuve Hospital, Montpellier University Hospital, Centre de Référence Maladies rénales rares Sorare, Montpellier, France.

Ariane Zaloszyc (A)

Pediatric Nephrology Unit, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.

Georges Deschênes (G)

Pediatric Nephrology Unit, Robert Debré Hospital, Centre de Référence Maladies rénales rares Marhea, APHP, Paris, France.

Linda Valeri (L)

Department of Psychiatry, Harvard Medical School and McLean Hospital, Boston, Massachusetts, USA.

Ludivine Launay (L)

INSERM-UCN U1086 Anticipe, Centre de Lutte contre le Cancer François Baclesse, Caen, France.

Cécile Couchoud (C)

Agence de la Biomédecine, La Plaine-Saint Denis, France.

Karen Leffondré (K)

University of Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France; INSERM, Clinical Investigation Center-Clinical Epidemiology-CIC-1401, Bordeaux, France.

Jérôme Harambat (J)

University of Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France; INSERM, Clinical Investigation Center-Clinical Epidemiology-CIC-1401, Bordeaux, France; Pediatric Nephrology Unit, Pellegrin-Enfants Hospital, Bordeaux University Hospital, Centre de Référence Maladies rénales rares Sorare, Bordeaux, France. Electronic address: jerome.harambat@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH